ADC Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509245863

Publication Date:

September 3, 2024

Pages:

133

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

The ADC platform is designed to generate ADCs with superior safety profiles, sustainable payload delivery and release in tumors, and efficient bystander killing of antigen-low and negative cells.
The global market for ADC Platform was estimated to be worth US$ 4400 million in 2023 and is forecast to a readjusted size of US$ 13840 million by 2030 with a CAGR of 18.9% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ADC Platform, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of ADC Platform by region & country, by Type, and by Application.
The ADC Platform market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ADC Platform.
Market Segmentation
By Company
Nerviano Medical Sciences
Creative Biolabs
Citrix Systems
AstraZeneca
Mersana
Seagen
ADC Therapeutics
Biocytogen
Heidelberg Pharma AG
Sutro
Synaffix
Genovis Group
Adcendo
WuXi Discovery Services
Daiichi Sankyo
Lonza
LEPU BIOPHARMA
HUABO BIOPHARMA
WuXi Biologics
Segment by Type:
Software Platform
Serve
Segment by Application
Oncology
BioPharmaceuticals
Rare Disease
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of ADC Platform manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of ADC Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of ADC Platform in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 ADC Platform Product Introduction
1.2 Global ADC Platform Market Size Forecast
1.3 ADC Platform Market Trends & Drivers
1.3.1 ADC Platform Industry Trends
1.3.2 ADC Platform Market Drivers & Opportunity
1.3.3 ADC Platform Market Challenges
1.3.4 ADC Platform Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global ADC Platform Players Revenue Ranking (2023)
2.2 Global ADC Platform Revenue by Company (2019-2024)
2.3 Key Companies ADC Platform Manufacturing Base Distribution and Headquarters
2.4 Key Companies ADC Platform Product Offered
2.5 Key Companies Time to Begin Mass Production of ADC Platform
2.6 ADC Platform Market Competitive Analysis
2.6.1 ADC Platform Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by ADC Platform Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADC Platform as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Software Platform
3.1.2 Serve
3.2 Global ADC Platform Sales Value by Type
3.2.1 Global ADC Platform Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global ADC Platform Sales Value, by Type (2019-2030)
3.2.3 Global ADC Platform Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncology
4.1.2 BioPharmaceuticals
4.1.3 Rare Disease
4.2 Global ADC Platform Sales Value by Application
4.2.1 Global ADC Platform Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global ADC Platform Sales Value, by Application (2019-2030)
4.2.3 Global ADC Platform Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global ADC Platform Sales Value by Region
5.1.1 Global ADC Platform Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global ADC Platform Sales Value by Region (2019-2024)
5.1.3 Global ADC Platform Sales Value by Region (2025-2030)
5.1.4 Global ADC Platform Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America ADC Platform Sales Value, 2019-2030
5.2.2 North America ADC Platform Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe ADC Platform Sales Value, 2019-2030
5.3.2 Europe ADC Platform Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific ADC Platform Sales Value, 2019-2030
5.4.2 Asia Pacific ADC Platform Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America ADC Platform Sales Value, 2019-2030
5.5.2 South America ADC Platform Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa ADC Platform Sales Value, 2019-2030
5.6.2 Middle East & Africa ADC Platform Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions ADC Platform Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions ADC Platform Sales Value
6.3 United States
6.3.1 United States ADC Platform Sales Value, 2019-2030
6.3.2 United States ADC Platform Sales Value by Type (%), 2023 VS 2030
6.3.3 United States ADC Platform Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe ADC Platform Sales Value, 2019-2030
6.4.2 Europe ADC Platform Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe ADC Platform Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China ADC Platform Sales Value, 2019-2030
6.5.2 China ADC Platform Sales Value by Type (%), 2023 VS 2030
6.5.3 China ADC Platform Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan ADC Platform Sales Value, 2019-2030
6.6.2 Japan ADC Platform Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan ADC Platform Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea ADC Platform Sales Value, 2019-2030
6.7.2 South Korea ADC Platform Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea ADC Platform Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia ADC Platform Sales Value, 2019-2030
6.8.2 Southeast Asia ADC Platform Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia ADC Platform Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India ADC Platform Sales Value, 2019-2030
6.9.2 India ADC Platform Sales Value by Type (%), 2023 VS 2030
6.9.3 India ADC Platform Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Nerviano Medical Sciences
7.1.1 Nerviano Medical Sciences Profile
7.1.2 Nerviano Medical Sciences Main Business
7.1.3 Nerviano Medical Sciences ADC Platform Products, Services and Solutions
7.1.4 Nerviano Medical Sciences ADC Platform Revenue (US$ Million) & (2019-2024)
7.1.5 Nerviano Medical Sciences Recent Developments
7.2 Creative Biolabs
7.2.1 Creative Biolabs Profile
7.2.2 Creative Biolabs Main Business
7.2.3 Creative Biolabs ADC Platform Products, Services and Solutions
7.2.4 Creative Biolabs ADC Platform Revenue (US$ Million) & (2019-2024)
7.2.5 Creative Biolabs Recent Developments
7.3 Citrix Systems
7.3.1 Citrix Systems Profile
7.3.2 Citrix Systems Main Business
7.3.3 Citrix Systems ADC Platform Products, Services and Solutions
7.3.4 Citrix Systems ADC Platform Revenue (US$ Million) & (2019-2024)
7.3.5 AstraZeneca Recent Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Profile
7.4.2 AstraZeneca Main Business
7.4.3 AstraZeneca ADC Platform Products, Services and Solutions
7.4.4 AstraZeneca ADC Platform Revenue (US$ Million) & (2019-2024)
7.4.5 AstraZeneca Recent Developments
7.5 Mersana
7.5.1 Mersana Profile
7.5.2 Mersana Main Business
7.5.3 Mersana ADC Platform Products, Services and Solutions
7.5.4 Mersana ADC Platform Revenue (US$ Million) & (2019-2024)
7.5.5 Mersana Recent Developments
7.6 Seagen
7.6.1 Seagen Profile
7.6.2 Seagen Main Business
7.6.3 Seagen ADC Platform Products, Services and Solutions
7.6.4 Seagen ADC Platform Revenue (US$ Million) & (2019-2024)
7.6.5 Seagen Recent Developments
7.7 ADC Therapeutics
7.7.1 ADC Therapeutics Profile
7.7.2 ADC Therapeutics Main Business
7.7.3 ADC Therapeutics ADC Platform Products, Services and Solutions
7.7.4 ADC Therapeutics ADC Platform Revenue (US$ Million) & (2019-2024)
7.7.5 ADC Therapeutics Recent Developments
7.8 Biocytogen
7.8.1 Biocytogen Profile
7.8.2 Biocytogen Main Business
7.8.3 Biocytogen ADC Platform Products, Services and Solutions
7.8.4 Biocytogen ADC Platform Revenue (US$ Million) & (2019-2024)
7.8.5 Biocytogen Recent Developments
7.9 Heidelberg Pharma AG
7.9.1 Heidelberg Pharma AG Profile
7.9.2 Heidelberg Pharma AG Main Business
7.9.3 Heidelberg Pharma AG ADC Platform Products, Services and Solutions
7.9.4 Heidelberg Pharma AG ADC Platform Revenue (US$ Million) & (2019-2024)
7.9.5 Heidelberg Pharma AG Recent Developments
7.10 Sutro
7.10.1 Sutro Profile
7.10.2 Sutro Main Business
7.10.3 Sutro ADC Platform Products, Services and Solutions
7.10.4 Sutro ADC Platform Revenue (US$ Million) & (2019-2024)
7.10.5 Sutro Recent Developments
7.11 Synaffix
7.11.1 Synaffix Profile
7.11.2 Synaffix Main Business
7.11.3 Synaffix ADC Platform Products, Services and Solutions
7.11.4 Synaffix ADC Platform Revenue (US$ Million) & (2019-2024)
7.11.5 Synaffix Recent Developments
7.12 Genovis Group
7.12.1 Genovis Group Profile
7.12.2 Genovis Group Main Business
7.12.3 Genovis Group ADC Platform Products, Services and Solutions
7.12.4 Genovis Group ADC Platform Revenue (US$ Million) & (2019-2024)
7.12.5 Genovis Group Recent Developments
7.13 Adcendo
7.13.1 Adcendo Profile
7.13.2 Adcendo Main Business
7.13.3 Adcendo ADC Platform Products, Services and Solutions
7.13.4 Adcendo ADC Platform Revenue (US$ Million) & (2019-2024)
7.13.5 Adcendo Recent Developments
7.14 WuXi Discovery Services
7.14.1 WuXi Discovery Services Profile
7.14.2 WuXi Discovery Services Main Business
7.14.3 WuXi Discovery Services ADC Platform Products, Services and Solutions
7.14.4 WuXi Discovery Services ADC Platform Revenue (US$ Million) & (2019-2024)
7.14.5 WuXi Discovery Services Recent Developments
7.15 Daiichi Sankyo
7.15.1 Daiichi Sankyo Profile
7.15.2 Daiichi Sankyo Main Business
7.15.3 Daiichi Sankyo ADC Platform Products, Services and Solutions
7.15.4 Daiichi Sankyo ADC Platform Revenue (US$ Million) & (2019-2024)
7.15.5 Daiichi Sankyo Recent Developments
7.16 Lonza
7.16.1 Lonza Profile
7.16.2 Lonza Main Business
7.16.3 Lonza ADC Platform Products, Services and Solutions
7.16.4 Lonza ADC Platform Revenue (US$ Million) & (2019-2024)
7.16.5 Lonza Recent Developments
7.17 LEPU BIOPHARMA
7.17.1 LEPU BIOPHARMA Profile
7.17.2 LEPU BIOPHARMA Main Business
7.17.3 LEPU BIOPHARMA ADC Platform Products, Services and Solutions
7.17.4 LEPU BIOPHARMA ADC Platform Revenue (US$ Million) & (2019-2024)
7.17.5 LEPU BIOPHARMA Recent Developments
7.18 HUABO BIOPHARMA
7.18.1 HUABO BIOPHARMA Profile
7.18.2 HUABO BIOPHARMA Main Business
7.18.3 HUABO BIOPHARMA ADC Platform Products, Services and Solutions
7.18.4 HUABO BIOPHARMA ADC Platform Revenue (US$ Million) & (2019-2024)
7.18.5 HUABO BIOPHARMA Recent Developments
7.19 WuXi Biologics
7.19.1 WuXi Biologics Profile
7.19.2 WuXi Biologics Main Business
7.19.3 WuXi Biologics ADC Platform Products, Services and Solutions
7.19.4 WuXi Biologics ADC Platform Revenue (US$ Million) & (2019-2024)
7.19.5 WuXi Biologics Recent Developments
8 Industry Chain Analysis
8.1 ADC Platform Industrial Chain
8.2 ADC Platform Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 ADC Platform Sales Model
8.5.2 Sales Channel
8.5.3 ADC Platform Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Nerviano Medical Sciences
Creative Biolabs
Citrix Systems
AstraZeneca
Mersana
Seagen
ADC Therapeutics
Biocytogen
Heidelberg Pharma AG
Sutro
Synaffix
Genovis Group
Adcendo
WuXi Discovery Services
Daiichi Sankyo
Lonza
LEPU BIOPHARMA
HUABO BIOPHARMA
WuXi Biologics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂